Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Mild clinical course of COVID-...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption

Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption

Bibliographic Details
Main Authors: Judit Demeter, Julia Weisinger, Zsolt Nagy
Format: Article
Language:English
Published: PAGEPress Publications 2021-02-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
chronic myeloid leukemia
TKI
COVID-19
Online Access:https://www.mjhid.org/index.php/mjhid/article/view/4513
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.mjhid.org/index.php/mjhid/article/view/4513

Similar Items

  • Monitoring the response to tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML)
    by: Ibrahim C. Haznedaroglu
    Published: (2014-08-01)
  • WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
    by: İbrahim C. Haznedaroğlu, et al.
    Published: (2020-02-01)
  • Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution
    by: Nuno Cerveira, et al.
    Published: (2018-12-01)
  • Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials
    by: Fateen Ata, et al.
    Published: (2023-12-01)
  • De‐escalation or discontinuation of tyrosine kinase inhibitor in patients with chronic myeloid leukemia: A multicentral, open‐label, prospective trial in China
    by: Jie Luo, et al.
    Published: (2022-11-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs